Lyra Therapeutics Inc.

09/20/2021 | Press release | Distributed by Public on 09/20/2021 05:02

Lyra Therapeutics Announces Four Abstracts Selected for Presentations at Upcoming ERS and ARS Meetings, Including New LANTERN 6-Month Follow-Up and Pharmacokinetic Data